Trial · NCT02706886
Participant flow81
How many started, completed or left each group, period by period.
21 to 40 of 81
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Part A: SAD Period | NOT COMPLETED | Part A: SAD: Lumasiran 1.0 mg/kg | 0 | |
| Part A: SAD Period | NOT COMPLETED | Part A: SAD: Lumasiran 3.0 mg/kg | 2 | |
| Part A: SAD Period | NOT COMPLETED | Part A: SAD: Lumasiran 6.0 mg/kg | 0 | |
| Part A: SAD Period | NOT COMPLETED | Part B: MAD: Placebo | 0 | |
| Part A: SAD Period | NOT COMPLETED | Part B: MAD: Lumasiran 1.0 mg/kg qM | 0 | |
| Part A: SAD Period | NOT COMPLETED | Part B: MAD: Lumasiran 3.0 mg/kg qM | 0 | |
| Part A: SAD Period | NOT COMPLETED | Part B: MAD: Lumasiran 3.0 mg/kg q3M | 0 | |
| Part B: MAD Study Days 1-85 | STARTED | Part A: SAD: Placebo | 0 | |
| Part B: MAD Study Days 1-85 | STARTED | Part A: SAD: Lumasiran 0.3 mg/kg | 0 | |
| Part B: MAD Study Days 1-85 | STARTED | Part A: SAD: Lumasiran 1.0 mg/kg | 0 | |
| Part B: MAD Study Days 1-85 | STARTED | Part A: SAD: Lumasiran 3.0 mg/kg | 0 | |
| Part B: MAD Study Days 1-85 | STARTED | Part A: SAD: Lumasiran 6.0 mg/kg | 0 | |
| Part B: MAD Study Days 1-85 | STARTED | Part B: MAD: Placebo | 3 | |
| Part B: MAD Study Days 1-85 | STARTED | Part B: MAD: Lumasiran 1.0 mg/kg qM | 7 | |
| Part B: MAD Study Days 1-85 | STARTED | Part B: MAD: Lumasiran 3.0 mg/kg qM | 7 | |
| Part B: MAD Study Days 1-85 | STARTED | Part B: MAD: Lumasiran 3.0 mg/kg q3M | 3 | |
| Part B: MAD Study Days 1-85 | COMPLETED | Part A: SAD: Placebo | 0 | |
| Part B: MAD Study Days 1-85 | COMPLETED | Part A: SAD: Lumasiran 0.3 mg/kg | 0 | |
| Part B: MAD Study Days 1-85 | COMPLETED | Part A: SAD: Lumasiran 1.0 mg/kg | 0 | |
| Part B: MAD Study Days 1-85 | COMPLETED | Part A: SAD: Lumasiran 3.0 mg/kg | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02706886/flow?page=2